Literature DB >> 2591321

Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo.

C Ffrench-Constant1, R O Hynes.   

Abstract

The primary gene transcript for the adhesive extracellular matrix glycoprotein fibronectin (FN) is alternatively spliced in three regions (EIIIA, EIIIB and V). At least one of these regions (V) has been shown to encode cell-binding sites, suggesting that splicing represents a mechanism to create functionally different forms of FN at different times and places. In order to test this hypothesis, we have examined the extent of alternative splicing of fibronectin during embryonic development. The distribution of the different spliced forms of FN mRNA in developing chicken embryos was determined using probes specific for the spliced regions in ribonuclease protection and in situ hybridization experiments. At embryonic day 2-4 (E2-4), all three spliced regions were included wherever FN mRNA was detected. At E16, however, we found spatially distinct splicing differences within the embryo, with cell-type-specific splicing excluding EIIIA and/or EIIIB in some tissues. In contrast, we did not detect exclusion of the V region. In a more detailed developmental study of the simplest of these tissues, the chorioallantoic membrane, we found that EIIIB was preferentially excluded after the completion of growth. These results suggest that FN splicing is used during development as a mechanism to create different forms of FN within the extracellular matrix by the inclusion or exclusion of specific segments. The data are consistent with an essential role for one of these segments, EIIIB, in the migration and/or proliferation of embryonic cells prior to their terminal differentiation and also suggest possible roles for the EIIIA segment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591321     DOI: 10.1242/dev.106.2.375

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  60 in total

1.  Loss of EDB+ fibronectin isoform is associated with differentiation of alveolar epithelial cells in human fetal lung.

Authors:  H Arai; H Hirano; S Mushiake; M Nakayama; G Takada; K Sekiguchi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Heart genetics in a small package, exploiting the condensed genome of Ciona intestinalis.

Authors:  Christina D Cota; Fernando Segade; Brad Davidson
Journal:  Brief Funct Genomics       Date:  2013-09-04       Impact factor: 4.241

3.  In vitro splicing of fibronectin pre-mRNAs.

Authors:  P A Norton; R O Hynes
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

4.  Characterization of mouse fibronectin alternative mRNAs reveals an unusual isoform present transiently during liver development.

Authors:  G K Górski; M C Aros; P A Norton
Journal:  Gene Expr       Date:  1996

Review 5.  The extracellular matrix in development and morphogenesis: a dynamic view.

Authors:  Tania Rozario; Douglas W DeSimone
Journal:  Dev Biol       Date:  2009-10-23       Impact factor: 3.582

Review 6.  Brain repair: lessons from developmental biology.

Authors:  C Ffrench-Constant; G A Mathews
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 7.  Embryonic angiogenesis: a review.

Authors:  J Wilting; B Christ
Journal:  Naturwissenschaften       Date:  1996-04

8.  Adult skin wounds in the fetal environment heal with scar formation.

Authors:  M T Longaker; D J Whitby; M W Ferguson; H P Lorenz; M R Harrison; N S Adzick
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

9.  Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.

Authors:  Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

10.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.